rs202160831

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007327.4(GRIN1):​c.258+18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00165 in 1,597,266 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 2 hom. )

Consequence

GRIN1
NM_007327.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.631

Publications

0 publications found
Variant links:
Genes affected
GRIN1 (HGNC:4584): (glutamate ionotropic receptor NMDA type subunit 1) The protein encoded by this gene is a critical subunit of N-methyl-D-aspartate receptors, members of the glutamate receptor channel superfamily which are heteromeric protein complexes with multiple subunits arranged to form a ligand-gated ion channel. These subunits play a key role in the plasticity of synapses, which is believed to underlie memory and learning. Cell-specific factors are thought to control expression of different isoforms, possibly contributing to the functional diversity of the subunits. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
GRIN1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • developmental and epileptic encephalopathy 101
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 9-137139762-C-T is Benign according to our data. Variant chr9-137139762-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 384370.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00127 (193/152236) while in subpopulation NFE AF = 0.00175 (119/68014). AF 95% confidence interval is 0.00149. There are 0 homozygotes in GnomAd4. There are 93 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN1NM_007327.4 linkc.258+18C>T intron_variant Intron 1 of 19 ENST00000371561.8 NP_015566.1 Q05586-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN1ENST00000371561.8 linkc.258+18C>T intron_variant Intron 1 of 19 1 NM_007327.4 ENSP00000360616.3 Q05586-1

Frequencies

GnomAD3 genomes
AF:
0.00127
AC:
193
AN:
152118
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00480
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00175
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00144
AC:
356
AN:
247846
AF XY:
0.00150
show subpopulations
Gnomad AFR exome
AF:
0.000310
Gnomad AMR exome
AF:
0.000926
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00394
Gnomad NFE exome
AF:
0.00178
Gnomad OTH exome
AF:
0.000819
GnomAD4 exome
AF:
0.00170
AC:
2450
AN:
1445030
Hom.:
2
Cov.:
28
AF XY:
0.00170
AC XY:
1227
AN XY:
719678
show subpopulations
African (AFR)
AF:
0.000271
AC:
9
AN:
33188
American (AMR)
AF:
0.00101
AC:
45
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.0000384
AC:
1
AN:
26044
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39606
South Asian (SAS)
AF:
0.000978
AC:
84
AN:
85922
European-Finnish (FIN)
AF:
0.00395
AC:
209
AN:
52854
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5748
European-Non Finnish (NFE)
AF:
0.00184
AC:
2020
AN:
1097138
Other (OTH)
AF:
0.00119
AC:
71
AN:
59834
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
125
250
374
499
624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00127
AC:
193
AN:
152236
Hom.:
0
Cov.:
32
AF XY:
0.00125
AC XY:
93
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41534
American (AMR)
AF:
0.000196
AC:
3
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4812
European-Finnish (FIN)
AF:
0.00480
AC:
51
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00175
AC:
119
AN:
68014
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00151
Hom.:
0
Bravo
AF:
0.000880

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 20, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 11, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 17, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
9.4
DANN
Benign
0.91
PhyloP100
0.63
PromoterAI
0.0074
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202160831; hg19: chr9-140034214; API